Skip to main content
All lobbying filings

BUCHANAN INGERSOLL & ROONEY PC

Lobbying for GENERIC ANIMAL DRUG ALLIANCE · Professional trade association for generic animal drug products.

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · Maryland · House · Senate · posted Jul 22, 2025

Official filing document

 Bills named in this filing 2
  • HR 1683
    Generic Animal Drug Advancement Act
  • HR 1418
    Animal Drug and Animal Generic Drug User Fee Amendments of 2023
 Lobbying activity 4
Health Issues

Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions

Pharmacy

Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions

Medical/Disease Research/Clinical Labs

Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions

Animals

Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem